Author

María Inés Barría

Universidad San SebastiánORCID 0000-0001-6225-5971Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Research Focus:variant calling· 1 Organism:virus· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Francisco Fuentes‐VillalobosiD· 2 shared José Luis Velasco GarridoiD· 2 shared Camila KossackiD· 1 shared Carlos FarkasiD· 1 shared Claudio QuevedoiD· 1 shared COVID 19 South Chile Group· 1 shared Felipe AguileraiD· 1 shared Ian E. BurbulisiD· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Francisco Fuentes‐VillalobosORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyeLifePeer-reviewedOct 29, 2024

Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression

Matías A. Medina, Francisco Fuentes‐Villalobos, Claudio Quevedo…·María Inés Barría

The paper identifies genes from the natural killer cell-mediated cytotoxicity pathway as critical in determining clinical outcomes of COVID-19 by analyzing longitudinal transcriptional changes in immune cells.

DOI 10.7554/elife.94242.3

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsPeerJPeer-reviewedMay 21, 2020

Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions

Carlos Farkas, Francisco Fuentes‐Villalobos, José Luis Velasco Garrido…·María Inés Barría

The paper analyzes early mutational events in SARS-CoV-2 sequences from different regions, identifying founder mutations and their clonal effects.

42 citations

viruswhole-genome sequencing

𝕏 PostBluesky